PRJNA768321
New blaVIM-2 variant, blaVIM-63, in pathogenic clinical isolates
Characterization of a novel blaVIM-2 type Metallo-beta-Lactamase, blaVIM-63, in clinical isolates of Pseudomonas aeruginosa and Citrobacter freundii, combining genomic approaches and phenotyping characterization.